Last reviewed · How we verify
NCT05228522
Preventing Diabetes in Latino Families
NA trial testing Lifestyle Intervention in Type 2 Diabetes in 132 participants. Participants enrolled and being followed up; not accepting new ones.
15 January 2026
Quick facts
| Lead sponsor | Arizona State University |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 132 |
| Start date | 12 December 2021 |
| Primary completion | 15 January 2026 |
| Estimated completion | 31 July 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Lifestyle Intervention
Conditions studied
- Type 2 Diabetes — all drugs for Type 2 Diabetes →
- Obesity — all drugs for Obesity →
- Pediatric Obesity — all drugs for Pediatric Obesity →
Sponsor
Arizona State University
Who can join
Adults 10 to 99, any sex, with Type 2 Diabetes or Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Purpose: This study will test the efficacy of a family-focused lifestyle intervention for reducing type 2 diabetes (T2D) risk factors and increasing Quality of Life (QoL) among high-risk Latino families.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Preventing diabetes in Latino families: A protocol for a randomized control trial.
Braxton ME, Nwabichie E, Diaz M, Lish E, et al · · 2023 · cited 2× · PMID 37852533 · DOI 10.1016/j.cct.2023.107361
Verify or expand the search:
- PubMed search for NCT05228522
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Lifestyle Intervention
Trials testing the same drug.
- NCT07310407 — Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) · Phase 2 · not yet recruiting
- NCT07341841 — Assessing Obesity Related Risk Factors in Adult Population: A Genetic and Behavioral Study · NA · enrolling by invitation
- NCT07085923 — Norwegian Mental Illness Heart Health Study · NA · recruiting
- NCT06741865 — The INSPIRE Study: Intervention Strategies for Preserving Intellectual Resilience and Engagement · NA · recruiting
- NCT06158204 — Improving Metabolic & Mental Health in Female Healthcare Shift Workers · NA · active not recruiting
Other recruiting trials for Type 2 Diabetes
Currently open trials in the same condition.
- NCT07053319 — SGLT2i, Pioglitazone, and Ketone Production in T2D · Phase 1 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07463859 — Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabet · NA · recruiting
- NCT07254689 — The Food for Health Study · NA · recruiting
- NCT07558863 — Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes · Phase 4 · recruiting
Other Arizona State University trials
Trials by the same sponsor.
- NCT07519408 — Acute Kidney Injury and Ultra-endurance Running · NA · not yet recruiting
- NCT05784467 — Methamphetamine, PrEP, and Intersectional Stigma Study · NA · not yet recruiting
- NCT07375043 — Drumming Groups for Parents of Autistic Children · NA · not yet recruiting
- NCT07297901 — App-based Breathing Program for Migraine Relief · NA · enrolling by invitation
- NCT06721793 — The Impact of a Caffeinated Sports Drink on Performance · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05228522 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 29 May 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Arizona State University
- Last refreshed: 12 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05228522.